Reborn 80s

Chapter 506 Hundred Billion Level

At the end of the year, it always seems very busy.

There is no need for Chen Huaiqing to deal with specific matters, but for some matters, Chen Huaiqing must make up his mind.

For example, the matter of Mota Group's dividends.

Last year, Mota Group had a very good life.

The combined revenue of motorcycles and automobiles, the main business of the entire group, has reached more than 1100 billion.

These two items alone brought a net profit of 176 billion to the Mota Group.

In addition to the complete vehicle business, such as engines, in addition to self-use, they are also sold externally.

For example, Changan Automobile, Shuchuan Automobile, and Jialin Hejian are all customers of Mota Power.

They can buy the latest engine of Mota Power.

In fact, for them, it is also a good thing to buy an engine powered by Mota Power without their own research and development capabilities.

Other domestic manufacturers also purchased engines from Mota Power.

120 million motorcycle engines and [-] automobile engines were sold out.

In addition, there are some other miscellaneous incomes, such as Mota Agriculture, etc. The total revenue of Mota Group has reached 1460 billion.

This does not include some companies in which the Murta Group has a stake.

For example, Mota-based companies such as Mota Semiconductor, Mota Microelectronics, and Mota Aircraft.

As well as companies like Xiangjiang Yuanmao, Xiangjiang Yuanmao has never handed over profits to the Mota Group headquarters.

In the financial report, the net profit of Mota Group is not too high, because the research and development investment continues to rise.

The market is used to Mota Group spending money on research and development.

Therefore, everyone no longer pays much attention to the net profit of the Mota Group, but pays more attention to the revenue of the Mota Group.

Compared with the financial report announced to the public, the report Chen Huaiqing read at this time has more detailed and accurate information.

"The second machine tool looks like it can be profitable!"

The sales volume of the second machine tool has increased a lot.

Not only in domestic sales, but also internationally, the second machine tool has gradually begun to sell some machine tool products.

Although internationally speaking, the products sold by the second machine tool are only second- and third-rate machine tool products.

It can't stand the extremely high price advantage.

Only by continuously letting products enter the market can we know what the market is like.

It is absolutely impossible for a company not to work hard in the market.

Only in the market can we understand the market and know the direction of our efforts.

Effort alone is not enough.

You have to work hard in the right direction, and work hard in the wrong direction. The more you work hard, the more serious your mistakes will be.

As far as Chen Huaiqing is concerned, he doesn't care whether the second machine tool is profitable or not.

What he cares more about is the continuous breakthroughs in the technology of the second machine tool.

Machine tool is the foundation of a country's equipment manufacturing, known as the mother of manufacturing, and its technical level represents the comprehensive competitiveness of a country.

How does Huaguo's machine tool technology rank in the world?

Dare to say with certainty that it definitely belongs to the forefront level.

Globally, there are not many countries that can manufacture their own machine tools.

Of course, at the current level of Huaguo machine tool technology, if you want to enter the top ten, you will definitely not be able to.

Chen Huaiqing has enough patience in the development of the second machine tool. It is only 1992 now, and it takes another 20 years to develop it. A small progress is made every year. After 20 years, it is a big step forward.

Song Qi sat on Chen Huaiqing's desk with a water glass in his hand, and there was black tea in the water glass.

A drink for women recommended by Mota Institute of Biology and Medicine.

The research scope of the Mota Institute of Biology and Medicine is quite broad.

Under the Mota Institute of Biology and Medicine, there are many various research institutes, including research on life sciences, Chinese patent medicines, and western medicines.

This research institute is affiliated to Mota Biomedical Group Co., Ltd.

In addition to the Mota Institute of Biology and Medicine, Mota Biomedical Group has Mota Hospital, pharmaceutical companies, and medical device companies.

Although the Mota Biomedical Group has the word Mota, it has nothing to do with the Mota Group in the legal sense.

If you have to say it, it is the major shareholder of the two companies, both of which are Mito Investment.

Mito Investment is the absolute controlling shareholder of Mota Biopharmaceutical Group. In addition to Mito Investment, Shuchuan State-owned Assets and Pension Fund also have shares.

Mota Biopharmaceutical Group has invested heavily in the research and development of new drugs and medical devices.

Basic medical equipment, such as infusion tubes, medical gloves, masks, and surgical instruments, are all produced.

Now these things are quite scarce in China.

Yes, it is quite scarce.

Mota Hospital is a large consumer among these, but the domestic production is insufficient, so it can only invest in itself.

In addition to providing these basic medical devices, the most important thing for Murta Medical Devices is to develop and produce monitors, ventilators, blood cell analyzers, urine analyzers, ultrasound machines, X-ray machines, etc.

Anyway, what is lacking now, Mota Medical Devices is researching.

For example, what kind of artificial lung (ECMO), Motta Medical Devices is also researching and developing.

NMR is also being developed.

This thing is expensive!
The price of one set is tens of millions, and it cannot be shut down, and it will cost hundreds of thousands to restart after shutting down once.

Anyway, it is an expensive word.

The nuclear magnetic resonance instrument has not been around for a long time in foreign countries, and it was only started to be used in 1973.

Therefore, there is only a gap of more than ten years. There is a gap, but it is not big.

MRI is very important for diagnosis.

Compared with the talent and experience of doctors in traditional Chinese medicine, what is modern medicine?

Pipeline-style standardized training of doctors.

It is to make doctors become workers of the production line, and display all kinds of physical data of the whole person in front of doctors through various instruments. Doctors no longer rely on experience to make medical diagnoses, but rely on various tests. Data, forming a standardized process for the entire medical activity.

Is it so good?
The biggest advantage is that most diseases can be treated quickly and easily.

There are standardized treatment procedures out there.

As for the intractable diseases...

Ordinary doctors can't do anything about it.

There is no need for a general doctor to treat it, and you can go to a higher-level hospital.

"I don't want to make profits, as long as I don't continue to expand losses."

Chen Huaiqing said with a smile: "We have to have confidence in our R&D personnel. As long as we are technologically advanced, won't it be a matter of making money every minute?"

The treatment offered by the second machine tool to employees is naturally extremely good, and the number of R&D personnel is also the largest among domestic machine tool companies.

Of course, no matter how good the treatment is, it is still considered low compared to the treatment of foreign machine tool companies.

less than one-fifth of it.

The low cost of labor naturally makes the cost of the entire second machine tool much lower.

The cost is lower than others, that is a huge competitive advantage.

In the market, the second machine tool can obtain a large number of users by virtue of its low price strategy.

(End of this chapter)